Vejon COVID-19 Review

Vejon COVID-19 Review

Share this post

Vejon COVID-19 Review
Vejon COVID-19 Review
Preparing for a different COVID-19 pandemic - Likely outcomes in China
Playback speed
×
Share post
Share post at current time
Share from 0:00
0:00
/
0:00
Preview
19

Share this post

Vejon COVID-19 Review
Vejon COVID-19 Review
Preparing for a different COVID-19 pandemic - Likely outcomes in China
15

Preparing for a different COVID-19 pandemic - Likely outcomes in China

Dr Philip McMillan's avatar
Dr Philip McMillan
Dec 26, 2022
∙ Paid
19

Share this post

Vejon COVID-19 Review
Vejon COVID-19 Review
Preparing for a different COVID-19 pandemic - Likely outcomes in China
15
Share

Sharing the research thoughts from the experience of challenge studies with SARS-COV vaccines.

Vejon COVID-19 Review
Why was a vaccine not developed against SARS-COV?
This question recently came to me as I reflected on the current state of the pandemic and increased excess mortality across the globe. What was the issue with vaccines for SARS-COV? Whilst SARS-COV2 is a novel coronavirus virus, it has 80% similarity to the original SARS-COV virus which caused the epidemic in 2003. Severe acute respiratory syndrome (SARS…
Read more
3 years ago · 56 likes · 23 comments · Dr Philip McMillan

Slides

The full video is for paid subscribers

Already a paid subscriber? Sign in
Vejon COVID-19 Review
Vejon COVID-19 Review
Authors
Dr Philip McMillan's avatar
Dr Philip McMillan
© 2025 Philip McMillan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share